Emergence of carbapenem-resistant Escherichia coli producing CMY-2-type AmpC β-lactamase in Brazil

Journal of Medical Microbiology

Volumn 57, Issue 12, 2008, Pages 1590-1592

  Pavez, Mónica ^a   Neves, Patrícia ^a   Dropa, Milena ^a   Matté, Maria H ^a   Grinbaum, Renato S ^b   Elmor De Araújo, Maria R ^b   Mamizuka, Elsa M ^a   Lincopan, Nilton ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL BENEFICÊNCIA PORTUGUESA DE SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; BACTERIAL ENZYME; BETA LACTAMASE AMPC; CARBAPENEM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOXITIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; FLUCONAZOLE; IMIPENEM; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BRAZIL; CANDIDIASIS; CASE REPORT; CATHETER INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENE AMPLIFICATION; GENOTYPE; HUMAN; HYDROLYSIS; LETTER; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BRAZIL; CARBAPENEMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FATAL OUTCOME; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

EID: 57749179739     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.2008/002774-0     Document Type: Letter

References (15)

1. Arakawa, Y., Shibata, N., Shibayama, K., Kurokawa, H., Yagi, T., Fujiwara, H. & Goto, M. (2000). Convenient test for screening metallo-beta-lactamase-producing Gram-negative bacteria by using thiol compounds. J Clin Microbiol 38, 40-43.
2. Bauernfeind, A., Stemplinger, I., Jungwirth, R. & Giamarellou, H. (1996). Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob Agents Chemother 40, 221-224.
3. Clarke, B., Hiltz, M., Musgrave, H. & Forward, K. R. (2003). Cephamycin resistance in clinical isolates and laboratory-derived strains of Escherichia coli, Nova Scotia, Canada. Emerg Infect Dis 9, 1254-1259.
4. CLSI (2005). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard. CLSI document M7-A6, 6th edn. Wayne, PA: Clinical and Laboratory Standards Institute.
5. Doi, Y. & Paterson, D. L. (2007). Detection of plasmid-mediated class C beta-lactamases. Int J Infect Dis 11, 191-197.
6. Lartigue, M. F., Poirel, L., Poyart, C., Réglier-Poupet, H. & Nordmann, P. (2007). Ertapenem resistance of Escherichia coli. Emerg Infect Dis 13, 315-317.
7. Lincopan, N., McCulloch, J. A., Reinert, C., Cassettari, V. C., Gales, A. C. & Mamizuka, E. M. (2005). First isolation of metallo-β- lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil. J Clin Microbiol 43, 516-519.
8. Lincopan, N., Leis, R., Vianello, M. A., de Araújo, M. R., Ruiz, A. S. & Mamizuka, E. M. (2006). Enterobacteria producing extended-spectrum beta-lactamases and IMP-1 metallo-beta-lactamases isolated from Brazilian hospitals. J Med Microbiol 55, 1611-1613.
9. Liu, Y. F., Yan, J. J., Ko, W. C., Tsai, S. H. & Wu, J. J. (2008). Characterization of carbapenemnon-susceptible Escherichia coli isolates from a university hospital in Taiwan. J Antimicrob Chemother 61, 1020-1023.
10. Mammeri, H., Nordmann, P., Berkani, A. & Eb, F. (2008). Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli. FEMS Microbiol Lett 282, 238-240.
11. Pasteran, F. G., Otaegui, L., Guerriero, L., Radice, G., Maggiora, R., Rapoport, M., Faccone, D., Di Martino, A. & Galas, M. (2008). Klebsiella pneumoniae carbapenenemase-2, Buenos Aires, Argentina. Emerg Infect Dis 14, 1178-1180.
12. Poirel, L., Héritier, C., Spicq, C. & Nordmann, P. (2004). In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J Clin Microbiol 42, 3831-3833.
13. Radice, M., Cittadini, R., Stortz, M., Ruggiero, M., Gutkind, G. & Vay, C. (2007). Emergence of plasmid-mediated AmpC β-lactamases in ESBL-producing enterobacteria in Buenos Aires, Argentina. In Abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 17-20 September 2007, p. 131. Washington, DC: American Society for Microbiology.
14. Rapoport, M., Monzani, V., Pasteran, F., Morvay, L., Faccone, D., Petroni, A. & Galas, M. (2008). CMY-2-type plasmid-mediated AmpC beta-lactamase finally emerging in Argentina. Int J Antimicrob Agents 31, 385-387.
15. Villegas, M. V., Lolans, K., Correa, A., Suarez, C. J., Lopez, J. A., Vallejo, M., Quinn, J. P.; Colombian Nosocomial Resistance Study Group (2006). First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother 50, 2880-2882.